Date | Time | Source | Headline | Symbol | Company |
08/09/2016 | 7:00PM | GlobeNewswire Inc. | Cancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company Updates | NASDAQ:CGIX | Cancer Genetics Inc |
08/09/2016 | 4:05PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CGIX | Cancer Genetics Inc |
08/01/2016 | 5:00PM | GlobeNewswire Inc. | Cancer Genetics to Report Second Quarter Earnings on Wednesday, August 10 | NASDAQ:CGIX | Cancer Genetics Inc |
07/22/2016 | 4:05PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
07/19/2016 | 4:23PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CGIX | Cancer Genetics Inc |
07/19/2016 | 4:07PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:CGIX | Cancer Genetics Inc |
07/18/2016 | 9:30AM | GlobeNewswire Inc. | Cancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug Developmen... | NASDAQ:CGIX | Cancer Genetics Inc |
07/13/2016 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CGIX | Cancer Genetics Inc |
07/12/2016 | 5:10PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CGIX | Cancer Genetics Inc |
06/30/2016 | 4:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
06/30/2016 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Receives New York State Approval for Focus::CLL™, a Unique NGS Panel for Chronic Lymphocytic Leukemia... | NASDAQ:CGIX | Cancer Genetics Inc |
06/29/2016 | 7:58AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Expands Its Immuno-Oncology Franchise With The Addition of The FDA-Approved VENTANA PD-L1 (SP142) Assay... | NASDAQ:CGIX | Cancer Genetics Inc |
06/27/2016 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics Names Healthcare Technology Industry Veteran John Jay Roberts as COO and Executive Vice President of Finance | NASDAQ:CGIX | Cancer Genetics Inc |
06/23/2016 | 8:25AM | GlobeNewswire Inc. | Cancer Genetics, Inc. and Sayre Therapeutics Announce Distribution Agreement to Commercialize CGI’s Proprietary FDA-cleared... | NASDAQ:CGIX | Cancer Genetics Inc |
06/07/2016 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics, Inc. to Present at the 2016 LD Micro Invitational Investor Conference | NASDAQ:CGIX | Cancer Genetics Inc |
06/06/2016 | 8:00AM | GlobeNewswire Inc. | HTG Molecular Diagnostics and Cancer Genetics Announce Presentation of an Immuno-Oncology Study at the American Society of Cl... | NASDAQ:CGIX | Cancer Genetics Inc |
05/26/2016 | 5:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CGIX | Cancer Genetics Inc |
05/26/2016 | 5:18PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/a) | NASDAQ:CGIX | Cancer Genetics Inc |
05/25/2016 | 4:18PM | Edgar (US Regulatory) | Small Company Offering and Sale of Securities Without Registration (d) | NASDAQ:CGIX | Cancer Genetics Inc |
05/24/2016 | 9:51AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CGIX | Cancer Genetics Inc |
05/23/2016 | 4:06PM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:CGIX | Cancer Genetics Inc |
05/20/2016 | 9:09AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
05/20/2016 | 9:00AM | GlobeNewswire Inc. | Cancer Genetics Announces $5 Million Registered Direct Offering | NASDAQ:CGIX | Cancer Genetics Inc |
05/17/2016 | 7:30AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision M... | NASDAQ:CGIX | Cancer Genetics Inc |
05/10/2016 | 4:20PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CGIX | Cancer Genetics Inc |
05/10/2016 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CGIX | Cancer Genetics Inc |
05/10/2016 | 4:01PM | GlobeNewswire Inc. | Cancer Genetics, Inc. Announces 39% Revenue Increase and Provides Recent Company Highlights | NASDAQ:CGIX | Cancer Genetics Inc |
05/05/2016 | 7:14AM | GlobeNewswire Inc. | Cancer Genetics, Inc. to Present at Pioneers 2016 Conference Presented by Joseph Gunnar & Co., LLC | NASDAQ:CGIX | Cancer Genetics Inc |
05/04/2016 | 8:35AM | GlobeNewswire Inc. | Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Tr... | NASDAQ:CGIX | Cancer Genetics Inc |
05/03/2016 | 7:36PM | GlobeNewswire Inc. | Cancer Genetics to Report First Quarter 2016 Financial Results on Tuesday, May 10th | NASDAQ:CGIX | Cancer Genetics Inc |